Evidence map›Paper›PMID 40399393›Full record

ArticleScientific reports2025

Binding properties and biological applications of green synthesized ZnO nanoparticles from neem flower.

Palanivelmurugan Mohanasundaram, Mary Saral A

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Palanivelmurugan MohanasundaramDepartment of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
Mary Saral ADepartment of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India. amarysaral@vit.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc oxide (ZnO) nanoparticles exhibit distinctive electronics, sensors, and biomedical applications. The present work aims to synthesize an eco-friendly, cost-effective, and sustainable approach for the fabrication of zinc oxide nanoparticles (ZnO NPs). An aqueous extract of neem flowers was used to fabricate the ZnO NPs as a natural reducing and capping agent. Analytical techniques, including UV-Vis, TEM, FTIR, FESEM, XRD, zeta potential analysis, and TGA confirmed the successful formation, crystalline nature, and stability of the ZnO NPs. The synthesized ZnO NPs were confirmed by the peak at 363 nm in the UV-Vis spectrum. The average particle size was found between 30 ~ 60 nm by FESEM, TEM, and Particle Size Analysis. The ZnO NP shows the highest % of inhibition was found to be > 80% in antioxidant activity. The antimicrobial assays show promising activity against pathogens. Moreover, their interaction with biomolecules such as DNA and bovine serum albumin (BSA) demonstrated strong binding affinity, highlighting their potential for biomedical applications. Cytotoxicity analysis using HEK-293 cells revealed minimal toxicity, suggesting that these nanoparticles are safe for normal cells. This study highlights the potential of green-synthesized ZnO nanoparticles as a promising option for therapeutic, antimicrobial, and bioengineering applications.

Indexed as

FlowersMetal NanoparticlesNanoparticlesZinc OxideAnimalsAnti-Bacterial AgentsAnti-Infective AgentsAntioxidantsGreen Chemistry TechnologyHEK293 CellsHumansMicrobial Sensitivity TestsParticle SizePlant ExtractsSerum Albumin, BovineSpectroscopy, Fourier Transform InfraredAnti-Bacterial AgentsAnti-Infective AgentsAntioxidantsPlant ExtractsSerum Albumin, BovineZinc OxideBinding propertyCytotoxicityGreen synthesisNeem flowerZinc oxide NP

Identifiers

PMID40399393
PMCPMC12095587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.